Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Oral Lixivaptan Capsules in Subject With Euvolemic Hyponatremia

PHASE3CompletedINTERVENTIONAL
Enrollment

106

Participants

Timeline

Start Date

April 30, 2008

Primary Completion Date

June 30, 2010

Conditions
Hyponatremia With Normal Extracellular Fluid Volume
Interventions
DRUG

lixivaptan

oral capsule

DRUG

placebo

oral capsule

Trial Locations (71)

1480

Centre Hospitalier de Tubize, Tubize

3000

UZ Gasthulsberg, Leuven

10016

Research Site, New York

12200

Research Site, Berlin

12208

Research Site 1, Albany

13353

Research Site, Berlin

14215

Erie County Medical Center, Buffalo

17011

Research Site 1, Camp Hill

18901

Research Site 1, Doylestown

19104

Research Site 1, Philadelphia

19401

Research Site, Norristown

20037

The George Washington University Medical Faculty Associates, Washington D.C.

23507

The Glennan Center for Geriatrics and Gerontology, Norfolk

27983

Three Rivers Health and Rehabilitation, Windsor

29209

Research Site 1, Columbia

30167

Research Site, Hanover

30912

Research Site, Augusta

31419

RTR Medical Group, Savannah

33161

Healthcare Clinical Data, Inc, North Miami

33331

Cleveland Clinic Florida, Weston

35392

Research Site, Giessen

36617

Research Site 1, Mobile

39120

Research Site, Magdeburg

42003

Four Rivers Clinical Research, Inc., Paducah

43609

Kettlie Joseph Daniels MD, Inc, Toledo

45005

Atrium Medical Center, Middletown

52242

Research Site 1, Iowa City

60612

Research Site, Chicago

64128

Research Site, Kansas City

69120

Research Site, Heidelberg

70114

Louisiana Research Associates, Inc., New Orleans

77074

Clinical Trial Network, Houston

78464

Research SIte, Konstanz

78626

SunStar Geriatrics Healthcare, Georgetown

80045

Research Site, Aurora

80336

Research Site, München

84058

Aspen Clinical Research, Orem

85050

PsyPharma Global, Phoenix

89106

Research Site 1, Las Vegas

90033

Research Site, Los Angeles

90073

Research Site 1, Los Angeles

95661

Research Site 1, Roseville

97080

Research Site, Würzburg

98405

Internal Medicine Northwest, Tacoma

110060

Sir Ganga Ram Hospital, Old Rajinder Nagar

302017

Fortis Escorts Hospital, Jaipur

673004

Baby Memorial Hospital, Calicut

02478

Research Site, Belmont

02135

Research Site, Boston

02212

Research Site, Boston

02215

Beth Israel Deaconess Medical Center, Boston

02903

Research Site, Providence

J4V 2H1

Research SIte, Greenfield Park

H1T 2M4

Research Site 1, Montreal

H4J 1C5

Research Site, Montreal

01307

Research Site, Dresden

411 030

Poona Hospital and Research Centre, Pune

110 065

Vidya Sagar Institute of Mental Health and Neurosciences, New Delhi

411 004

Deenanath Mengeshkar Hospital & Research Centre, Erandawane

08-300

Research Site 1, Podlaski

Unknown

Research Site 1, Warsaw

22-400

Samodzielny Publiczny Szpital Wojewodzki im. Papieza Jana Pawla II, Zamość

85-094

Research Site, Bydgoszcz

06400

Research Site 1, Ciechanów

40-027

Research Site, Katowice

90-153

Research Site 1, Lodz

20-954

Research Site, Lublin

02-097

Research Site 1, Warsaw

Research Site, Warsaw

02-507

Research Site 1, Warsaw

90-302

Niepubliczny Zaklad Opieki Zdrowotney, Wilgury

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Cardiokine Biopharma, LLC

INDUSTRY

collaborator

Biogen

INDUSTRY

lead

CardioKine Inc.

INDUSTRY

NCT00660959 - Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Oral Lixivaptan Capsules in Subject With Euvolemic Hyponatremia | Biotech Hunter | Biotech Hunter